Novel agents for the treatment of hyponatremia: a review of conivaptan and tolvaptan.

Abstract

Hyponatremia is the most commonly encountered electrolyte abnormality. If uncorrected, it can lead to seizure, coma, or death due to brain stem herniation. Once the serum osmolality and volume status of the patient is determined, treatment should be initiated to correct the serum sodium by 8 to 12 mEq/L within the first 24 hours. Arginine vasopressin (AVP… (More)
DOI: 10.1097/CRD.0b013e3181f5b3b7

2 Figures and Tables

Cite this paper

@article{FergusonMyrthil2010NovelAF, title={Novel agents for the treatment of hyponatremia: a review of conivaptan and tolvaptan.}, author={Nadia Ferguson-Myrthil}, journal={Cardiology in review}, year={2010}, volume={18 6}, pages={313-21} }